Presbyopia Physician November eUpdate

Nov 10, 2022

Ocuphire initiates Global License Agreement for Nyxol eye drops across 3 indications

Nov 8, 2022

Ocuphire reaches license agreement for the development and commercialization of Nyxol

Nov 8, 2022

Ocuphire enters global license agreement with Famy for Nyxol development

Nov 8, 2022

Ocuphire Enters into a Global License Agreement for Development and Commercialization of Nyxol Eye Drops

Nov 7, 2022

Presbyopia: How are the Drops Performing?

Jul 10, 2022

Presbyopia-correcting drops broaden options for younger patients

Jul 1, 2022

So Many Options Coming! What Differences Do We See So Far?

Jun 1, 2022

Ocuphire Pharma's Mina Sooch

May 1, 2022

Ophthalmology Management eUpdate

Mar 9, 2022

• 1
• 2
• 3
• 4
• Next »